- Home
- TMDX vs IBTA Comparison
TMDX vs IBTA Comparison
Compare TMDX & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- IBTA
- Stock Information
- Founded
- TMDX 1998
- IBTA 2011
- Country
- TMDX United States
- IBTA United States
- Employees
- TMDX N/A
- IBTA N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IBTA
- Sector
- TMDX Health Care
- IBTA
- Exchange
- TMDX Nasdaq
- IBTA Nasdaq
- Market Cap
- TMDX 2.3B
- IBTA 2.2B
- IPO Year
- TMDX 2019
- IBTA 2024
- Fundamental
- Price
- TMDX $127.12
- IBTA $49.98
- Analyst Decision
- TMDX Buy
- IBTA Buy
- Analyst Count
- TMDX 10
- IBTA 10
- Target Price
- TMDX $122.89
- IBTA $74.60
- AVG Volume (30 Days)
- TMDX 1.2M
- IBTA 459.0K
- Earning Date
- TMDX 05-08-2025
- IBTA 05-14-2025
- Dividend Yield
- TMDX N/A
- IBTA N/A
- EPS Growth
- TMDX N/A
- IBTA 24.66
- EPS
- TMDX 1.41
- IBTA 2.03
- Revenue
- TMDX $488,227,000.00
- IBTA $369,501,000.00
- Revenue This Year
- TMDX $32.58
- IBTA $6.19
- Revenue Next Year
- TMDX $21.65
- IBTA $15.05
- P/E Ratio
- TMDX $90.23
- IBTA $24.57
- Revenue Growth
- TMDX 64.43
- IBTA 7.20
- 52 Week Low
- TMDX $55.00
- IBTA $31.40
- 52 Week High
- TMDX $177.37
- IBTA $107.89
- Technical
- Relative Strength Index (RSI)
- TMDX 76.52
- IBTA N/A
- Support Level
- TMDX $118.79
- IBTA N/A
- Resistance Level
- TMDX $130.48
- IBTA N/A
- Average True Range (ATR)
- TMDX 4.49
- IBTA 0.00
- MACD
- TMDX -0.15
- IBTA 0.00
- Stochastic Oscillator
- TMDX 83.53
- IBTA 0.00
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).